Get started
Author

P G Chu

Keratin expression in human tissues and neoplasms
2002 · P G Chu, L M Weiss · Histopathology · 841
Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker
2004 · Z Jiang, C L Wu, et al. · Histopathology · 135
Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours
2001 · P G Chu, M H Lyda, et al. · Histopathology · 100
Histological and immunohistochemical characterization of extranodal diffuse large‐cell lymphomas with prominent spindle cell features
2001 · J Wang, N C J Sun, et al. · Histopathology · 58
Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases
2001 · P G Chu, L M Weiss · Histopathology · 41
Functional inhibition of retinal pigment epithelial cell-substrate adhesion with a monoclonal antibody against the beta 1 subunit of integrin.
1991 · P G Chu, G B Grunwald · PubMed · 33
PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia
2010 · Q Huang, D S Snyder, et al. · Leukemia · 27
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome
2008 · G. Somlo, P. Chu, et al. · Annals of Oncology · 25
Usefulness of immunohistochemistry in delineating renal spindle cell tumours. A retrospective study of 31 cases
2004 · J Wang, L M Weiss, et al. · Histopathology · 18
PDF
Identification of the 2A10 antigen of retinal pigment epithelium as a beta 1 subunit of integrin.
1991 · P Chu, G B Grunwald · PubMed · 16
Identification of an adhesion-associated protein of the retinal pigment epithelium.
1990 · P G Chu, G B Grunwald · PubMed · 7
Inter-patient and intra-tumoral heterogeneity of oncogenic copy number alterations (CNAs) in gastric and gastroesophageal junction (GEJ) adenocarcinomas
2017 · J. Chao, V. Bedell, et al. · Annals of Oncology · 1
Abstract P3-05-02: Immune profiling of paired primary and recurrent triple negative breast cancer
2018 · T-F He, S Yost, et al. · Cancer Research
Abstract P1-05-26: Genomic analysis of molecular discordance of paired primary and recurrent triple negative breast cancer
2017 · Y Yuan, A Li, et al. · Cancer Research
Phase 2 Timing of Rectal Cancer Response to Chemoradiation: Analysis of Radiation Therapy (RT)
2013 · C.R. Thomas, J. Garcia-Aguilar, et al. · International Journal of Radiation Oncology*Biology*Physics
A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response
2013 · K. Zhang, C. Kim, et al. · Head & Neck Oncology
Prognostic relevance of ribonucleotide reductase small subunit p53R2 in pancreatic cancer
2009 · V. M. Chung, X. Liu, et al. · Journal of Clinical Oncology
Gene and protein expression profile and prognosis in high-risk primary breast cancer
2004 · G. Somlo, S. Schneider, et al. · Journal of Clinical Oncology
Imatinib mesylate therapy for recurrent Ewing's family of tumors (EFT)
2004 · W. A. Chow, P. Chu, et al. · Journal of Clinical Oncology
Prognostic indicators of relapse-free and overall survival in patients with high-risk primary breast cancer following high-dose chemotherapy
2001 · George Somlo, P Chu, et al. · Breast Cancer Research and Treatment
Works count: 20
Citation count: 1,285
H-index: 10
I10-index: 10
Year
Topic
Type